Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126171041 | 12617104 | 1 | I | 20160801 | 20160803 | 20160803 | EXP | FR-ROCHE-1806312 | ROCHE | RIVOIRARD R, CHARGARI C, GUY JB, NUTI C, PEOCH, FOREST F, TUAN FALK A, GARIN C, ADJABI A, HOARAU D, FOTSO MJ, ESCURE J, MORICEAU G, FOURNEL P, BOUTET C AND MAGNE N CLINICAL IMPACT OF BEVACIZUMAB IN PATIENTS WITH RELAPSED GLIOBLASTOMA: FOCUS ON A REAL-LIFE MONOCENTRIC SURVEY (SV1 STUDY). CHEMOTHERAPY 2016 FEB 25;61 (5):269-274. | 0.00 | Y | 0.00000 | 20160803 | OT | FR | FR |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 126171041 | 12617104 | 1 | PS | Bevacizumab | BEVACIZUMAB | 1 | Unknown | EACH CHEMOTHERAPY CYCLE WAS REPEATED EVERY 15 DAYS | U | 125085 | 10 | MG/KG | |||||||
| 126171041 | 12617104 | 2 | SS | IRINOTECAN | IRINOTECAN | 1 | Unknown | DOSE: 340 MG/M2 (WITH CONCOMITANT ENZYME-INDUCING ANTIEPILEPTIC DRUGS) OR 125 MG/M 2 (WITHOUT CONCOM | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 126171041 | 12617104 | 1 | Glioblastoma |
| 126171041 | 12617104 | 2 | Glioblastoma |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 126171041 | 12617104 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 126171041 | 12617104 | Anaemia | |
| 126171041 | 12617104 | Hepatotoxicity | |
| 126171041 | 12617104 | Leukopenia | |
| 126171041 | 12617104 | Lymphopenia | |
| 126171041 | 12617104 | Neutropenia | |
| 126171041 | 12617104 | Proteinuria | |
| 126171041 | 12617104 | Thrombocytopenia |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |